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Abstract
Background: The Diabetes Quality of Life (DQoL) questionnaire has been used frequently among people with diabetes. 
Aims: To develop and validate a revised Arabic version of the DQoL questionnaire for patients in Jordan with type 2 dia-
betes. 
Methods: We recruited patients with type 2 diabetes from 3 public health clinics in Jordan. The original DQoL question-
naire was translated to Arabic and then back-translated by a different translator, and the 2 versions were compared. Prior 
to circulating the final version of the questionnaire, a cognitive validity test was applied to ensure that all the questions 
were clear. The final Arabic version of the DQoL questionnaire, along with a questionnaire that included demographic and 
other health-related questions, were circulated to the participants. The questionnaire data were analysed using explora-
tory factor analysis and confirmatory factor analysis after excluding duplicated questions and questions that included 
> 10% missing data. Cronbach’s α was also conducted to confirm internal consistency. 
Results: Analysis validated an Arabic version of DQoL questionnaire that included 29 items divided into 3 factors: wor-
ries, impact and satisfaction. Different variables were associated with DQoL scores including insulin administration, low 
income status, marital status, and presence of diabetic complications. 
Conclusions: We validated an Arabic tool that can be used to evaluate QoL among Arabic-speaking patients with type 2 
diabetes. 
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Introduction
Diabetes mellitus (DM) is a widespread disorder that ef-
fects patients from different age groups and sexes, and is 
a complex disease that involves both genetic and environ-
mental factors. The most common forms of DM are type 
1 and type 2. Type 2 is characterized by insulin resistance 
and deficiency of insulin secretion. The 3 P symptoms are 
hallmarks for DM: polydipsia, polyuria and polyphagia. 
Other symptoms may include losing weight, fatigue, and 
resistant sores (1). DM may cause several complications if 
not controlled properly, including cardiac disease, stroke, 
retinopathy that may progress to blindness, kidney fail-
ure, and limb amputations resulting from progression of 
diabetic foot problems.
Quality of life (QoL) is a wide concept with many 
domains that measures satisfaction with life. QoL 
includes both health-related and non-health-related 
aspects. Non-health-related domains include economic, 
political, and social factors. Health-related QoL (HRQoL) 
evaluates how a person perceives the effect of a disease 
and its treatment on the quality of their life (2). rather 
than on the presence or absence of an illness when 
measuring health status. The World Health Organization 
(WHO) defines HRQoL as an individual’s physical, mental 
and social welfare and not only the absence of illness (3). 
Diabetes has a huge effect on the lives of patients, because 
of constant constraints including dieting, exercising and 
regular monitoring of blood sugar levels, in addition to 
complications that affect HRQoL. In patients who have 
had DM for 15 years, ~2% may suffer from blindness, 10% 
partial blindness, 30–45% some degree of retinopathy, 
10–20% nephropathy, and 20–35% neuropathy (4). These 
complications decrease HRQoL and increase the cost 
of DM management. The gradual worsening of these 
complications further aggravates the anxiety and 
depression that people with diabetes may have (5), with an 
estimated 20.3% having depression (6), which correlates 
with low HRQoL (7). Other complications associated 
with DM can also decrease HRQoL, including sexual 
dysfunction (8). Depression can also increase progression 
of diabetes due to low medication compliance (9). 
According to the International Diabetes Federation, 
12.8% of adults aged 20–79 years have diabetes, with 55 
million people in the Middle East North Africa (MENA) 
region. This region has the second highest prevalence of 
diabetes after North America and the Caribbean (10). In the 
MENA region diabetes and related complications caused 
death to 418,900 deaths – 16.2% of all deaths in adults aged 
20–79 years in 2019. The economic burden of the disease 
was estimated to be US$2.9 billion in 2019 (10). The IDF 
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estimates that 9.9% of Jordanians have diabetes (10). In 
2015, disability-adjusted life years because of diabetes 
were 1052 among Jordanian men and 965 among women 
(11). According to the Global Health Data Exchange, 14.24% 
of total deaths in Jordan in 2017 were caused by DM (12).
Therefore, a tool to measure HRQoL is important 
for appropriate management of DM; however, there 
is no validated tool for the Jordanian population. One 
widely used tool is the Diabetic Quality of Life (DQoL) 
questionnaire (13), which has demonstrated strong validity 
and reliability (14). The questionnaire has been translated 
into different languages and used in several countries 
including the United States of America (15), Malaysia 
(16), China (17), Turkey (18) and Spain (19). The DQoL 
questionnaire has been used in 82 studies (20); however, it 
has yet to be used in published studies in Arabic countries. 
The aims of the present study were, therefore, to validate 
an Arabic version of the questionnaire, evaluate QoL of 
patients with type 2 diabetes, and examine the factors 
that may influence it among the Jordanian population. 
Methods
Study design
The current study validated an Arabic version of the 
DQoL questionnaire to measure QoL in people with type 
2 diabetes. Patients were approached from 1 January to 
30 April 2019, at 3 government health clinics in Jordan 
(2 in the capital Amman and 1 in Madaba). These clin-
ics are characterized by close follow-up of patients and 
continuity of care as the patients must see a physician to 
obtain their prescriptions on a monthly basis. Two clin-
ics were chosen from Amman as almost 42% (21)  of the 
Jordanian population reside there. Additionally, the clin-
ics in the capital serve many patients from the surround-
ing areas that lack proper medical services. The clinic in 
Madaba received patients from both urban and rural are-
as and ~30% of Madaba residents reside in rural areas (21). 
Materials and procedure
The DQoL questionnaire (Appendix 1) has been used for 
several years in several countries and in different lan-
guages. The questionnaire is composed of 46 items divid-
ed into 3 factors: satisfaction (15 items), impact (20 items) 
and worries (11 items divided into social/vocational and 
diabetes-related). The satisfaction and impact questions 
included a 5-point Likert scale [very satisfied (1 point), 
quite satisfied, satisfied, little satisfied, and very dissat-
isfied (5 points)]. In the original English-language ques-
tionnaire, questions related to worries about diabetes are 
divided into 2 sections: worries about social/vocational 
issues and worries about the future effects of diabetes. 
Responses to these are dichotomous with Yes or No op-
tions. However, having dichotomous and 5-point Likert 
scales may cause serious issues when attempting to val-
idate questionnaires; therefore, these statements were 
converted to 5-point Likert scale responses. 
Construction of the Arabic version of the DQoL 
questionnaire started with translation and selection 
of the items to be included; redundancy in questions 
were evaluated and duplicated items were omitted to 
shorten the questionnaire and improve factor loadings 
and discriminant validity. Prior to circulating the 
questionnaire, 20 other participants were given cognitive 
interviews to ensure that all questions were clear to the 
respondents. The data from these 20 participants were 
not included in the final data analysis. 
Ethical approval was obtained from Al-Zaytoonah 
University and the 3 selected clinics. In addition to the 
DQoL questionnaire, a demographic data sheet was 
developed to obtain background information from 
participants including: sex, age, educational level, marital 
status, income level, and duration of illness. This data 
sheet, along with a consent form, a questionnaire that 
included other health-related questions and the final 
Arabic version of the DQoL questionnaire (Appendix 2) 
were circulated to 800 literate outpatients who had 
type 2 diabetes, and 725 of these agreed to participate. 
Relevant clinical indicators such as haemoglobin (Hb)
A1c, and diabetic complications and other comorbidities 
were collected from patients’ medical records. Diabetic 
complications included diabetic foot, neuropathy, 
nephropathy, retinopathy and cardiovascular diseases 
(CVDs; e.g., stable and unstable angina pectoris, and 
myocardial infarction). Medication information was also 
obtained from the records. 
There are several perspectives on how to estimate the 
appropriate sample size for factor analysis; some focus 
on the number of total participants, and others argue 
that sample size should be calculated using the ratio of 
the number of participants to number of items in the 
questionnaire, with a commonly suggested ratio of 20:1 
(22). Therefore, to obtain an appropriate sample size in 
accordance with the previously mentioned approaches, 
we required a sample size of 700 participants.
The survey was translated by 2 independent bilingual 
translators, who were native Arabic speakers and 
proficient in English. The 2 translations were compared, 
and changes were made accordingly. The questionnaire 
was recirculated to 50 patients in their next follow-up 
visit to evaluate test–rest reliability. The follow-up visit 
was ~30 days after the index visit.
Statistical analysis
In the final data analysis, items were evaluated based 
on response rates; items that had > 10% missing an-
swers were excluded. Estimation of missing values was 
important to recognize and ignore unrelated items. 
Prior to factor analysis, data imputation with maximi-
zation expectation procedure was applied to items that 
had missing data that did not reach the cut-off point 
of 10%. Exploratory factor analysis (EFA) was conduct-
ed using principal component analysis to evaluate the 
most suitable model for the study data. The Kaiser–
Meyer–Olkin value  and Bartlett’s Test of Sphericity 
were conducted to evaluate the suitability of the data 
for EFA. Communalities were examined, and any item 
< 0.4 was deleted. Parallel analysis was conducted, and 
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scree plots were examined to determine the appropriate 
number of factors to be extracted. A pattern matrix was 
generated using direct oblimin rotation, which was cho-
sen because the factors were significantly correlated. Any 
item that had a loading < 0.4 in all factors or had a loading 
of ≥ 0.4 in more than 1 factor were excluded. Discrimi-
nant validity was evaluated by examining the factor cor-
relation matrix. Internal consistency for each subscale 
was evaluated by calculating Cronbach’s α.
Confirmatory factor analysis (CFA) was conducted 
on the same data in accordance with Bengt Muthén’s 
method, to evaluate the model fit by examining different 
indicators, including: CMIN/DF (minimum discrepancy), 
which has an acceptable range of 2–5; comparative fit 
index (CFI), and Tucker–Lewis coefficient (TLI), ≥ 0.9 
is considered acceptable; and root mean square error of 
approximation (RMESA), ≤ 0.08 is considered acceptable. 
The percentage of participants who had the highest or 
lowest possible score were calculated to evaluate the 
presence of ceiling and floor effects; these effects were 
considered present if > 15% of the participants scored the 
maximum or minimum possible (23).
Four stepwise multiple linear regressions were 
conducted to evaluate factors associated with the DQoL 
questionnaire total mean score and the mean scores 
of each factor. These models included administration 
of insulin, glucagon-like peptide-1 receptor agonist, 
metformin, sulfonylurea, nonsulfonylurea, sodium–
glucose cotransporter-2 inhibitors, dipeptidyl peptidase 
4 inhibitors, and thiazolidinediones. The model also 
included number of drugs, number of complications 
(neuropathy, nephropathy, retinopathy, CVD, diabetic 
foot, hypertension or dyslipidaemia), HbA1c level, 
married status, low income, number of years having 
diabetes, age, sex, body mass index, and smoking status. 
Log transformation was performed to achieve linearity. 
Cook’s distance was calculated to measure the impact 
of influential cases on the model, and values > 1 was 
considered problematic. Normality of errors was assessed 
by examining standardized residual histograms and 
variance inflation factor (VIF) was calculated to evaluate 
multicollinearity. Finally, independence of errors was 
evaluated by the Durbin–Watson test. 
Pearson correlation was applied to evaluate test–
retest reliability. All statistical analysis was conducted 
using SPSS version 20 and Amos version 22.
Results
Nine duplicate items were identified and removed from 
the DQoL questionnaire (Table 1).
The questionnaires from 725 (378 male) participants 
were included in the analysis. The response rate was 
90.6%. Eight items were excluded from the analysis due 
to > 10% missing data; these items are listed in Table 2. 
Imputation of data on the remaining items was 
conducted using the maximization expectation 
procedure. EFA was conducted on the remaining 29 
items; the characteristics of the sample are displayed in 
Table 3. The only significant difference found between 
the sexes was in smoking status, which was significantly 
higher in men. 
Kaiser–Meyer–Olkin test result was 0.91 and Bartlett’s 
Test of Sphericity was χ2 (406) = 21975.94, P < 0.01. These 
results showed that the study data were suitable for 
factor analysis. Scree plots and parallel analysis indicated 
that a 3-factor model was suitable for the study data. 
The 3 factors were satisfaction, impact and worries. All 
the items included in the model loaded on their original 
factors as intended in the original English questionnaire. 
The communalities ranged between 0.45 and 0.95 and 
the loadings from 0.65 to 0.98 (Table 4). Cronbach’s α 
indicated good internal consistency in all 3 factors. 
The ceiling and floor effects were evaluated by 
calculating the percentage of participants that had the 
highest or lowest possible score, and none of factors 
reached the 15% cutoff point. CFA indicated a good fit for 
the suggested model: CMIN/DF = 4.88, CFI = 0.94, TLI = 
0.93 and RMSEA = 0.07.
Table 1 Items removed from Diabetes Quality of Life Questionnaire due to duplications
Item retained Item removed
S5. How satisfied are you with the flexibility you have in your diet? I9.   How often do you feel restricted by your diet? 
S6. How satisfied are you with the burden your diabetes is placing 
       on your family? 
I5.   How often does your diabetes interfere with your family life?
S8. How satisfied are you with your sleep? I6.   How often do you have a bad night’s sleep? 
S9. How satisfied are you with your social relationships and friendships? I7.   How often do you find your diabetes limiting your social 
        relationships and friendships? 
S10. How satisfied are you with your sex life? I10. How often does your diabetes interfere with your sex life? 
S13. How satisfied are you with the time you spend exercising? I12. How often does your diabetes interfere with your exercising? 
S11. How satisfied are you with your work, school, and household activities? I13. How often do you miss work, school, or household duties 
        because of your diabetes? 
W6. How often do you worry about whether you will miss work?
S 14. How satisfied are you with your leisure time? I15.  How often do you find that your diabetes interrupts your 
         leisure-time activities? 
I = impact; S = satisfaction; W = worries.
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The stepwise linear multiple regression (Table 5) 
indicated that the mean of the total score of DQoL 
questionnaire was associated with HbA1c, insulin 
treatment, number of complications, low-income group, 
diabetic foot, CVD and nephropathy. The model explained 
52.4% of the variance, the mean score for the Satisfaction 
factor was associated with HbA1c, insulin, diabetic foot, 
number of complications, being currently married, and 
CVD. The mean score for the Impact factor was associated 
with low income, HbA1c, insulin treatment, nephropathy, 
number of complications, diabetic foot, and CVD. The 
mean score for the Worries factor was associated with 
number of complications, HbA1c, and low income. 
Test–retest reliability was tested by using Pearson’s 
correlations and all the items had a correlation > 0.8, 
which indicated good test–retest reliability.
Discussion
We formulated and validated a summarized Arabic form 
of the DQoL questionnaire. The items in this study all 
loaded in their original designated scales in the original 
English questionnaire (13). However, our model consist-
ed of 29 items loaded in 3 scales only, worry, impact and 
satisfaction, unlike the original model that included 46 
items divided into 4 scales (13). This was mainly due to the 
exclusion of most of the items that were included in the 
vocational/social worry scale, mainly because of a high 
level of missing data (exceeding the 10% threshold limit). 
These items were irrelevant to many of our respondents; 
for example, “How often do you worry about whether 
you will get married?” as many of recruits were already 
married. This applied to the rest of the deleted items that 
asked about concerns regarding completing their educa-
tion, having children, getting a job and being covered by 
insurance. Additionally, item W6 was a duplicate of item 
S11; therefore, it was omitted from the questionnaire. The 
only item that remained from the original vocational/so-
cial worry scale was W7, which was loaded in the new 
worry scale. A previous study had also reported a large 
amount of missing data in these items as they did not ap-
ply to many of the respondents (16). The new formulated 
Worry scale comprised 4 items that were converted from 
dichotomous questions to 5-Likert scale questions to be 
more suitable for EFA. Other items from the Impact scale 
were also omitted to avoid redundancy, which shortened 
the 46-item lengthy survey to 29 items and improved its 
discriminant validity and factor loadings. 
The results of the Arabic version were also compared 
with the Malaysian version of the DQoL questionnaire 
(16). The result of the present study resembled the 3-factor 
model of the Malaysian version, which consists only of 18 
items, as more items were dropped that were identified 
as duplications, including (I14) “How often do you find 
yourself explaining what it means to have diabetes?”, and 
(I16) “How often do you tell others about your diabetes?”. 
However, we felt that these 2 questions were not identical 
as explaining the impact of diabetes is different from 
merely stating that you have diabetes. Other items had 
low communalities and thus were not included in the 
Malaysian version. 
Our study indicated that insulin has a negative effect 
on QoL. The literature reports contradictory finding 
when evaluating the effect of insulin therapy on QoL of 
people with diabetes (24). Insulin therapy can improve 
QoL (25), mainly due to better glycaemic control (26). In 
contrast, other studies have reported a negative effect of 
insulin therapy on QoL due to hypoglycaemic episodes 
(27), as well as the pain and inconvenience associated 
with insulin administration (28). Furthermore, insulin 
is usually prescribed in more severe cases (29) that are 
likely to have more complications. These conflicting 
findings may be due to variations in sampling and 
methodology (24), in addition to insulin type (25) and 
injection device (30). We also confirmed the previously 
reported association between HbA1c and QoL (31). Better 
QoL is likely to lead to better self-care behaviour, which 
results in lower HbA1c (9).
Currently married individuals had lower satisfaction 
when compared to unmarried patients. Several studies 
have reported a correlation between marital quality and 
adherence to diabetes care (32), and that marital stress is 
associated with an increase in serum glucose level due 
to the effect of stress hormones (32). The results of our 
study did not contain the omitted questions about sexual 
activity; if these questions were included this correlation 
may have been more significant.
As reported previously (33), low income was associated 
with low QoL. This may be attributed to the lack of 
knowledge of available options for managing DM (33), in 
addition to other lifestyle variables including nutritional 
intake.
Finally, as expected and as reported previously, the 
presence of different complications including diabetic 
foot CVD and nephropathy in addition to number of 
complications were all associated with lower QoL in our 
sample.
Table 2 Items excluded from analysis due to > 10% missing 
values
Item deleted
W1. How often do you worry about whether you will get married? 
W2. How often do you worry about whether you will have children? 
W3. How often do you worry about whether you will not get a job 
         you want? 
W4. How often do you worry about whether you will be denied 
         insurance?
W5. How often do you worry about whether you will be able to 
         complete your education?
W11. How often do you worry about whether someone will not go 
          out with you because you have diabetes?
I20. How often do you hide from others the fact that you are having 
         an insulin reaction?
S10. How satisfied are you with your sex life? 
I = impact; S = satisfaction; W = worries.
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We conducted cognitive interviews to ensure that 
the questions were clear for our sample of patients. 
Additionally, the high internal consistency confirmed 
the clarity of the questionnaire. The Arabic version 
of the DQoL questionnaire can therefore be used to 
measure HRQoL in patients with diabetes. Evaluating 
QoL is important when treating people with diabetes, 
as patients with low HRQoL may not comply with 
Table 3 Sample characteristics 
Variables Male (n = 378) Female (n = 347) P 
Age, years 58.1 (9.68) 58.97 (9.56) 0.22
HbA1c 7.44 (1.43) 7.36 (1.46) 0.50
No. of years of diabetes 7.65 (3.77) 7.99 (3.90) 0.23
No. of drugs 2.02 (0.92) 1.99 (0.86) 0.65
No. of complications 2.14 (1.21) 2.22 (1.24) 0.39
Smoking
Smoking 144 (38.1%) 31 (8.9 %) <0.01
Ex-smoker 54 (14.3%) 9 (2.6 %) −
Non-smoker 180 (47.6 %) 307 (88.5 %) −
BMI 
Underweight 9 (2.4%) 3 (0.9%) 0.13
Normal 53 (14 %) 45 (13%) −
Overweight 183 (48.4 %) 153 (44.1 %) −
Obesity 133 (35.2 %) 146 (42.1%) −
Marital status 
Single 47 (12.4%) 58 (16.7%) 0.42
Married 293 (77.5%) 253 (72.9%) −
Divorce 20 (5.3%) 19 (5.5%) −
Widow 18 (4.8%) 17 (4.9%) −
Income 104 (27.5%) 108 (31.1%) 0.29
Education 
Primary 75 (19.8%) 59 (17.0%) 0.13
Secondary 93 (24.6%) 78 (22.5%) −
Diploma 74 (19.6%) 53 (15.3%) −
Bachelor’s degree 128 (33.9%) 150 (43.2%) −
Higher degree 8 (2.1%) 7 (2.0%) −
Drugs 
Insulin 154 (40.7%) 126 (36.3%) 0.22
Metformin 375 (99.2 %) 338 (97.4%) 0.08
GLP1RA 22 (5.8 %) 28 (8.1 %) 0.24
Sulfonylurea 105 (27.8 %) 93 (26.8 %) 0.80
Thiazolidinediones 23 (6.1 %) 30 (8.6%) 0.20
Nonsulfonylurea 1 (0.3%) 3 (0.9%) 0.35
SGLT2 3 (0.8%) 3 (0.9%) 1.0
DPP4 inhibitor 79 (20.9 %) 68 (19.6 %) 0.71
Complications
Cardiovascular disease 67 (17.7 %) 60 (17.3 %) 0.92
Diabetic foot 25 (6.6%) 23 (6.6 %) 1.0
Neuropathy 75 (19.8%) 69 (19.9 %) 1.0
Nephropathy 41 (10.8 %) 43 (12.4%) 0.56
Retinopathy 57 (15.1 %) 70 (20.2 %) 0.08
Hypertension 237 (62.7%) 216 (62.2%) 0.94
Dyslipidaemia 307 (81.2 %) 289 (83.3%) 0.5
Results presented as mean (SD) or frequency (percentage). Kaiser–Meyer–Olkin test result was 0.91 and Bartlett’s test of sphericity was χ2 (406) = 21975.94, P < 0.01. 
BMI = body mass index; DPP4 inhibitor = dipeptidyl peptidase-4 inhibitor; GLP1RA = glucagon-like peptide 1 receptor agonist; HbA1c = haemoglobin A1c; SGLT2 = sodium–glucose cotransporter 2.
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important medical instructions that influence control of 
their condition (9). Therefore, using the Arabic version 
of DQoL could help in the management of diabetes, 
and future work may include measuring the benefit of 
detection and management of DQoL when managing 
patients with diabetes in Jordan and neighbouring Arab 
countries. Furthermore, the Arabic version of the DQoL 
questionnaire can be used to compare the QoL in patients 
with diabetes in Arabic-speaking countries, which has 
not been possible until now. It will also be possible to 
make comparisons between HRQoL among patients with 
diabetes, relying on data collected using the English-
language version of the questionnaire. 
Our data showed some similarities and some 
differences with other work focusing on diabetes 
conducted in Arab countries. For example, using the 
Audit of Diabetes Dependent Quality of Life (ADDQOL19), 
Al-Shehri found that Saudi women with diabetes had 
significantly poorer QoL than men had  (34). This 
replicates other research conducted in Gaza (35)  using 
the WHO Quality of Life-BREF (WHOQOL-BREF), which 
found that women with diabetes were more negatively 
affected than men. These findings contrast with ours, 
but as Al-Shehri noted, such differences may be in part 
due to wider gender inequalities in some communities, 
which were perhaps less evident in our Jordanian sample. 
Our results do replicate those of other work in relation 
to complications. We found poorer QoL for those with 
complications, supporting studies in Saudi Arabia using 
the Short Form-36 questionnaire (SF-36). 
One limitation of our study was that illiterate patients 
were not included, who may have struggled more with 
medication instructions related to the management of 
their condition. Another limitation was that dropping the 
17 questions could have affected the content validity of 
the questionnaire, particularly the impact of diabetes on 
sex life, and may not have captured the complete impact 
of diabetes in all groups. However, summarizing the 
questionnaire and limiting duplication will encourage 
patients to participate and complete the questionnaire 
accurately. Furthermore, this summarized version is 
more applicable to all ages and different marital status, 
which makes it easier to conduct in a general setting 
without needing different versions for specific groups. 
Moreover, in a conservative society as in Jordan and other 
Arabic countries, many would be reluctant to talk openly 
about their sexual activities. In fact, high nonresponse 
rates have been reported in privacy-related items from 
the DQoL questionnaire, in addition to many respondents 
complaining about the length of the questionnaire. 
Conclusion
This validated Arabic version of the DQoL questionnaire 
could be used to evaluate HRQoL in Arab-speaking pa-
tients by examining the overall score and the scores of 
the different subscales. This could aid with diagnosis and 
management of DM in Jordan and neighbouring coun-
tries.
Funding: None.
Competing interests: None declared.










Satisfaction items (S1–S9, S11–S15) 0.65–0.98 0.45–0.95 0.97 0.63–0.97 2.81
Impact items (I1–I4, I8, I11, I14–I19) 0.71–0.83 0.52–0.71 0.94 0.67–0.7 2.06
Worries items (W7–W10) 0.79–0.91 0.69–0.79 0.88 0.73–0.75 2.39
Table 5 Multiple regression results for different factors affecting the scores of Diabetic Quality of Life Questionnaire
Variables Mean total score Satisfaction Impact Worry
β P value 95% CI β P value 95% CI β P value 95% CI β P value 95% CI
HbA1c 0.15 <0.01 0.13–0.17 0.17 <0.01 0.13–0.20 0.15 <0.01 0.12–0.18 0.11 <0.01 0.06–0.15
Insulin 0.24 <0.01 0.18–0.31 0.23 <0.01 0.13–0.33 0.31 <0.01 0.21–0.4 N/S
Low income 0.19 <0.01 0.12–0.26 N/S 0.59 <0.01 0.48–0.69 0.15 0.022 0.02–0.28
Currently married N/S 0.16 <0.01 0.05–0.27 N/S N/S
Diabetic foot 0.3 <0.01 0.16–0.42 0.33 <0.01 0.11–0.54 0.28 <0.01 0.08–0.49 N/S
CVDs 0.19 <0.01 0.01–0.28 0.20 <0.01 0.06–0.34 0.21 <0.01 0.07–0.34 N/S
Nephropathy 0.18 <0.01 0.08–0.29 N/S 0.33 <0.01 0.17–0.49 N/S
Total complications 0.11 <0.01 0.08–0.15 0.12 <0.01 0.10–0.18 0.09 <0.01 0.03–0.14 0.16 <0.01 0.10–0.21
CI = confidence interval; CVDs = cardiovascular diseases; HbA1c = haemoglobin A1c; N/S = not significant.
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Élaboration et validation de la version arabe du questionnaire sur la qualité de vie 
des patients diabétiques
Résumé
Contexte : Le questionnaire sur la qualité de vie des patients diabétiques est fréquemment utilisé auprès de ces 
derniers.  
Objectifs : Élaborer et valider une version arabe révisée du questionnaire sur la qualité de vie des patients 
diabétiques pour les patients jordaniens atteints de diabète de type 2.  
Méthodes : Nous avons recruté des patients atteints de diabète de type 2 dans trois centres de santé publique en 
Jordanie. Le questionnaire original a été traduit en arabe. Il a ensuite fait l'objet d'une rétro-traduction par un 
traducteur différent, et les deux versions ont été comparées. Avant de diffuser la version finale du questionnaire, 
un test de validité cognitive a été appliqué pour s'assurer que toutes les questions étaient claires. La version arabe 
finale du questionnaire sur la qualité de vie des patients diabétiques, ainsi qu'un questionnaire comportant des 
questions démographiques et d'autres questions liées à la santé, ont été distribués aux participants. Les données 
issues du questionnaire ont été analysées à l'aide d'une analyse factorielle exploratoire et d'une analyse factorielle 
confirmatoire après exclusion des questions dupliquées et des questions comportant plus de 10 % de données 
manquantes. Le coefficient alpha de Cronbach a également été réalisé pour confirmer la cohérence interne.  
Résultats : L'analyse a permis de valider une version arabe du questionnaire comprenant 29 items répartis 
selon trois facteurs : inquiétudes, impact et satisfaction. Différentes variables ont été associées aux scores du 
questionnaire sur la qualité de vie des patients diabétiques, notamment l'administration d'insuline, le statut de 
revenu faible, le statut marital et la présence de complications diabétiques. 
Conclusions : Nous avons validé un outil en arabe qui peut être utilisé pour évaluer la qualité de vie chez les 
patients arabophones atteints de diabète de type 2. 
رّي والتحقق من صحتها إعداد النسخة العربية الستبيان جودة احلياة ملرىض داء الُسكَّ
وليد القريم، بثينة املعيا، جوناثان لينج
اخلالصة:
رّي.  رّي ُيستخدم كثريًا بني األشخاص املصابني بداء الُسكَّ اخللفية: كان استبيان جودة احلياة ملرىض داء الُسكَّ
رّي والتحقق من صحتها ملرىض النمط 2 من  األهداف: هدفت هذه الدراسة إىل إعداد نسخة عربية ُمنقحة الستبيان جودة احلياة ملرىض داء الُسكَّ
رّي يف األردن.  داء الُسكَّ
رّي من 3 عيادات للصحة العامة يف األردن. ولقد ُترمجت النسخة األصلية الستبيان  طرق البحث: استعنا بمرىض مصابني بالنمط 2 من داء الُسكَّ
رّي إىل اللغة العربية، ثم ُأعيدت ترمجتها مرة أخرى بواسطة ُمرتجم خمتلف، ثم قورنت النسختان. وقبل تعميم النسخة  جودة احلياة ملرىض داء الُسكَّ
النهائية لالستبيان، ُأجري اختبار التحقق من املعرفة لضامن وضوح مجيع األسئلة. وُعممت عىل املشاركني النسخة العربية النهائية الستبيان جودة 
رّي، إىل جانب استبيان آخر تضمن أسئلة سكانية وأخرى متعلقة بالصحة. وجرى حتليل بيانات االستبيان باستخدام التحليل  احلياة ملرىض داء الُسكَّ
كام   .%10 من  أكرب  بنسبة  ناقصة  بيانات  التي تضمنت  واألسئلة  املتكررة  األسئلة  استبعاد  بعد  التوكيدي،  العاميل  والتحليل  االستكشايف  العاميل 
اسُتخدم مقياس كرونباخ لتأكيد االتساق الداخيل. 
رّي الذي اشتمل عىل 29 بندًا مقساًم إىل 3 عوامل: املخاوف،  النتائج: أثبت التحليل صحة النسخة العربية الستبيان جودة احلياة ملرىض داء الُسكَّ
رّي، مثل إعطاء األنسولني، وحالة الدخل املنخفض،  واألثر، والرضا. وارتبطت متغريات خمتلفة بدرجات استبيان جودة احلياة ملرىض داء الُسكَّ
رّي.  واحلالة الزواجية، ووجود مضاعفات الُسكَّ
رّي الناطقني باللغة العربية. االستنتاجات: حتققنا من صحة أداة عربية يمكن استخدامها لتقييم استبيان جودة احلياة بني مرىض النمط 2 من داء الُسكَّ
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Appendix 1. Original Diabetes Quality of Life Questionnaire
Satisfaction
1. How satisfied are you with the amount of time it takes to manage your diabetes?
2. How satisfied are you with the amount of time you spend getting checkups?
3. How satisfied are you with the time it takes to determine your sugar level? 
4. How satisfied are you with your current treatment? 
5. How satisfied are you with the flexibility you have in your diet? 
6. How satisfied are you with the burden your diabetes is placing on your family? 
7. How satisfied are you with your knowledge about your diabetes?
8. How satisfied are you with your sleep?
9. How satisfied are you with your social relationships and friendships? 
10. How satisfied are you with your sex life? 
11. How satisfied are you with your work, school, and household activities? 
12. How satisfied are you with the appearance of your body? 
13. How satisfied are you with the time you spend exercising?
14. How satisfied are you with your leisure time? 
15. How satisfied are you with life in general?
Impact
1. How often do you feel pain associated with the treatment for your diabetes? 
2. How often are you embarrassed by having to deal with your diabetes in public? 
3. How often do you have low blood sugar?
4. How often do you feel physically ill?
5. How often does your diabetes interfere with your family life?
6. How often do you have a bad night's sleep? 
7. How often do you find your diabetes limiting your social relationships and 
friendships? 
8. How often do you feel good about yourself? 
9. How often do you feel restricted by your diet? 
10. How often does your diabetes interfere with your sex life? 
11. How often does your diabetes keep you from driving a car or using a machine (e.g., 
a typewriter)? 
12. How often does your diabetes interfere with your exercising? 
13. How often do you miss work, school, or household duties because of your diabetes? 
14. How often do you find yourself explaining what it means to have diabetes? 
15. How often do you find that your diabetes interrupts your leisure-time activities? 
16. How often do you tell others about your diabetes?
17. How often are you teased because you have diabetes?
18. How often do you feel that because of your diabetes you go to the bathroom more 
than others? 
19. How often do you find that you eat something you shouldn't rather than tell 
someone that you have diabetes?
20. How often do you hide from others the fact that you are having an insulin 
reaction?
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Worry: social/vocational
1. How often do you worry about whether you will get married? 
2. How often do you worry about whether you will have children? 
3. How often do you worry about whether you will not get a job you want? 
4. How often do you worry about whether you will be denied insurance?
5. How often do you worry about whether you will be able to complete your education
6. How often do you worry about whether you will miss work? 
7. How often do you worry whether you will be able to take a vacation?
Worry: diabetes-related 
8. How often do you worry about whether you will pass out? 
9. How often do you worry that your body looks different because you have diabetes? 
10. How often do you worry that you will get complications from your diabetes? 
11. How often do you worry about whether someone will not go out with you because 
you have diabetes?
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Appendix 2 Modified Arabic Diabetes Quality of Life Questionnaire
القسم األول: املعلومات الشخصية
 أنثى     1- اجلنس : ذكر
2- العمر: 
3- املستوى التعليمي :
 3-دراسات عليا     2- ثانوي    1- ابتدائي 
 5- دراسات عليا     4- بكالوريس
 4 - احلالة االجتامعية :
____________________________________________
5- متوسط الدخل : 
  1- اقل من 500 دينار /شهريا
  2- 500-1000  دينار /شهريا
 .3- أكثر من 1000 دينار
 6- سنوات االصابة باملرض : 
____________________________________________











العبارة  الرقم 
ما مدى رضاك عن مقدار الوقت الذي تستغرقه لعالج 
مرض السكري لديك؟
-1
 ما مدى رضاك عن مقدار الوقت الذي تقضيه يف إجراء 
الفحوصات؟
-2
ما مدى رضاك عن الوقت الذي تستغرقه لفحص 
مستوى السكر لديك؟
-3
ما مدى رضاك عن عالجك احلايل؟ -4
ما مدى رضاك عن مرونة نظامك الغذائي؟ -5
ما مدى رضا العبء الذي يفرضه مرضك عىل عائلتك؟ -6
ما مدى رضاك عن معرفتك بمرض السكري؟ -7
ما مدى رضاك عن نمط نومك؟ -8
ما مدى رضاك عن عالقاتك االجتامعية؟  -9
ما مدى رضاك عن عملك ومدرستك وأنشطتك 
املنزلية؟
-10
ما مدى رضاك عن مظهر جسمك؟  -11
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العبارة  الرقم 
ما مدى رضاك عن كمية الوقت الذي تقضيه يف التامرين 
الرياضية؟ 
-12
ما مدى رضاك عن كيفية قضاء وقت فراغك 
)اجازاتك(؟ 
-13
ما مدى رضاك عن احلياة بشكل عام؟  -14
القسم الثالث: التأثري 
5-طوال 
الوقت 
4-عادة  3-احيانا  2-قليل 
جدا 
1- ابدا العبارة الرقم
هل تشعر عادة بآالم يسببها عالج مرض السكري؟  -1
هل يتسبب لك التعامل مع مرض السكر يف األماكن العامة الشعور 
باحلرج؟
-2
هل ينخفض مستوى السكر لديك عادة؟ -3
هل تشعر بتعب جسدي بسبب مرض السكري عادة؟ -4
هل تشعر بالرضا عن نفسك عادة؟  -5
هل يمنعك مرض السكري من قيادة السيارة أو استخدام آلة )عىل 
سبيل املثال ، آلة كاتبة( عادة؟
-6
كم مرة تضطر اىل رشح ما يعنيه وجود مرض السكري؟ -7
هل خترب اآلخرين عادة عن مرض السكري؟ -8
هل اغاظك االخرون لعدم قدرتك عىل تناول احللويات بسبب 
إصابتك بمرض السكري؟
-9
هل تشعر أنك تضطر اىل استخدام احلامم كثريا بسبب مرض 
السكري؟
-10
هل تضطر اىل أكل طعام ال يناسب مرض السكري بدال من إخبار 
املحيطني بك بأنك مصاب بداء السكري؟ 
-11
القسم الرابع: القلق ذو صلة بمرض السكري 
5-طوال 
الوقت 
4-عادة  2-قليل  3-احيانا 
جدا 
1- ابدا العبارة الرقم
هل تقلق فيام يتعلق بقدرتك عىل أخذ إجازة؟ -1
هل تقلق بشأن تغّيبك عن الوعي عادة؟ -2
هل تقلق بسبب اختالف شكل جسدك بسبب مرض السكري؟ -3
هل تقلق بشأن تعرضك ملضاعفات مرض السكري يف املستقبل؟ -4
